Creative Planning’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $473K | Buy |
|
|||||
|
2025
Q2 | $402K | Sell |
|
|||||
|
2025
Q1 | $447K | Sell |
|
|||||
|
2024
Q4 | $915K | Buy |
|
|||||
|
2024
Q3 | $469K | Buy |
|
|||||
|
2024
Q2 | $435K | Buy |
|
|||||
|
2024
Q1 | $436K | Buy |
|
|||||
|
2023
Q4 | $356K | Buy |
|
|||||
|
2023
Q3 | $316K | Sell |
|
|||||
|
2023
Q2 | $355K | Sell |
|
|||||
|
2023
Q1 | $359K | Buy |
|
|||||
|
2022
Q4 | $339K | Sell |
|
|||||
|
2022
Q3 | $311K | Hold |
|
|||||
|
2022
Q2 | $352K | Buy |
|
|||||
|
2022
Q1 | $342K | Buy |
|
|||||
|
2021
Q4 | $219K | Buy |
|
|||||
|
2021
Q3 | $201K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $354K | Sell |
|
|||||
|
2020
Q4 | $375K | Buy |
|
|||||
|
2020
Q3 | $322K | Buy |
|
|||||
|
2020
Q2 | $273K | Buy |
|
|||||
|
2020
Q1 | $223K | Sell |
|
|||||
|
2019
Q4 | $297K | Buy |
|
|||||
|
2019
Q3 | $231K | Sell |
|
|||||
|
2019
Q2 | $264K | Buy |
|
|||||
|
2019
Q1 | $269K | Sell |
|
|||||
|
2018
Q4 | $250K | Buy |
|
|||||
|
2018
Q3 | $298K | Buy |
|
|||||
|
2018
Q2 | $253K | Sell |
|
|||||
|
2018
Q1 | $272K | Sell |
|
|||||
|
2017
Q4 | $347K | Buy |
|
|||||
|
2017
Q3 | $348K | Sell |
|
|||||
|
2017
Q2 | $348K | Buy |
|
|||||
|
2017
Q1 | $335K | Buy |
|
|||||
|
2016
Q4 | $275K | Sell |
|
|||||
|
2016
Q3 | $335K | Buy |
|
|||||
|
2016
Q2 | $302K | Sell |
|
|||||
|
2016
Q1 | $348K | Sell |
|
|||||
|
2015
Q4 | $503K | Buy |
|
|||||
|
2015
Q3 | $417K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $433K | Sell |
|
|||||
|
2014
Q4 | $383K | Buy |
|
|||||
|
2014
Q3 | $231K | Buy |
|
|||||
|
2014
Q2 | $208K | Buy |
|
|||||
|
2014
Q1 | $107K | Buy |
|
|||||
|
2013
Q4 | $89K | Buy |
|
|||||
|
2013
Q3 | $80K | Sell |
|
|||||
|
2013
Q2 | $79K | Buy |
|